Summary & Overview
CPT 95079: Ingestion Challenge Test, Additional 60 Minutes
CPT code 95079 denotes an add-on service for ingestion challenge testing, covering an additional 60 minutes of monitored testing after the initial 120 minutes. Ingestion challenge tests are clinically important for diagnosing food, drug, or other substance triggers of allergic reactions; extended monitoring can capture delayed responses and inform treatment planning. Nationally, accurate coding for extended challenge testing affects clinical documentation, utilization tracking, and insurer coverage determinations.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of the clinical context for extended ingestion challenges, typical sites of service, and how this add-on code fits into allergy diagnostic service lines. The publication provides benchmarks and practical billing considerations relevant to payers listed, explains common clinical scenarios where extended monitoring is used, and summarizes coding relationships and potential documentation expectations.
This overview is intended for clinicians, coding professionals, and payers seeking a concise reference on the purpose and clinical implications of CPT code 95079, highlighting why extended ingestion challenge time matters for patient diagnosis and care pathways.
Billing Code Overview
CPT code 95079 is an add-on ingestion challenge testing procedure that represents an additional 60 minutes of monitored testing after the initial 120 minutes of an ingestion challenge. In an ingestion challenge test, the provider administers suspected foods, drugs, or other substances in a controlled setting to identify triggers of an allergic response in an individual.
-
Service type: Allergy diagnostic testing — extended monitored ingestion challenge
-
Typical site of service: Allergy clinic, outpatient infusion or observation unit, or other monitored clinical setting capable of supervised oral or ingestion challenge testing
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 10-year-old child with a history of suspected food-induced anaphylaxis is referred to an allergist for a supervised oral food ingestion challenge. The patient has undergone prior skin testing and serum-specific IgE testing but remains clinically uncertain for tolerance to a suspected trigger (e.g., milk or peanut). The initial supervised ingestion challenge proceeds under continuous monitoring for the initial 120 minutes (standard monitored dosing and observation). After 120 minutes, the patient tolerates the cumulative dose but the clinician elects to continue observation and incremental dosing for an additional 60 minutes to assess for delayed or biphasic reactions or to administer further incremental amounts to reach a full portion. During the additional 60 minutes the provider documents ongoing vital sign monitoring, assessment of clinical signs (urticaria, wheeze, gastrointestinal symptoms), and readiness to treat adverse reactions (epinephrine, oxygen, IV access). The facility is equipped for immediate resuscitation. Documentation includes the indication for extended monitoring, exact start and stop times for the additional 60 minutes, the observed findings, any medications administered, and the decision rationale. Typical site of service is an outpatient allergy clinic, ambulatory infusion center, or hospital outpatient department with allergy/immunology services. This procedure is performed by an allergist/immunologist or qualified physician or advanced practice provider with specialized training in allergy challenges and emergency management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 |